Who’s laughing now? The upside of a risky market strategy w/ Emrah Gultekin

Being a health innovator during the COVID-19 Pandemic can be difficult — dwindling funding, shifting priorities, and challenges with getting your message to resonate with the right audience can make it seem darn near impossible.   But what if it isn’t? Running a lean, nimble, and focused path during any crisis, from financial to biological, can help startups remain in the game while also providing a chance to pivot their product to fulfill a current need. Or sometimes, more importantly, a future need.   In this episode, Emrah Gultekin, CEO of Chooch.AI discusses how his company was able to reteach its AI to read radiology scans and provide a much needed, quicker diagnostic tool to the healthcare industry during the COVID-19 crisis. Emrah’s insights include:   How crises can fuel innovation How the move towards human to technology interaction forced by COVID can help accelerate the adoption of technology-based innovations The importance of positioning your business horizontally so it can have options for growth, and be able to better navigate an unpredictable future How rapid cycle innovation can test innovation’s boundaries in positive ways Why staying lean and nimble can better position your company to survive some aspects of a crisis situation How the concept of “present bias” can hinder or help an innovator in times of uncertainty   Guest Bio Emrah Gultekin is an entrepreneur, innovator and the co-founder and CEO of Chooch.AI. Chooch is a Silicon Valley start-up and visual AI solution that provides fast, accurate facial authentication and object recognition for the media, advertising, banking, medical and security industries.    For those who want to learn more about Chooch.AI and how they may be able to help your company, you can reach out to them at  www.chooch.ai, or email them at hello@chooch.ai.